Medical Digest & Congress Report

Rajinder Suri shares his insights on which vaccination programs with pandemic potential have worked and what else can be done to repurpose COVID facilities and incorporate novel platforms at the World Vaccine Congress Washington 2025. Video: https://medicaldigest.org/scientific-contents/interview:which-vaccination-programs-pandemic-potential-have-worked-and-what-else-can-be-done-repurpose-covid-fa...

Olivera Finn shares her insights on clinical updates for a novel preventative breast cancer vaccine at the World Vaccine Congress Washington 2025. Video: https://medicaldigest.org/scientific-contents/interview:clinical-updates-novel-preventative-breast-cancer-vaccine

William Decker shares his insights on cell-based therapeutic vaccination as adjuvant therapy for MGMT unmethylated glioblastoma at the World Vaccine Congress Washington 2025. Video: https://medicaldigest.org/scientific-contents/interview:cell-based-therapeutic-vaccination-adjuvant-therapy-mgmt-unmethylated-glioblastoma

Amy Aspelund shares her insights on intranasal universal influenza vaccines at the World Vaccine Congress Washington 2025. Video: https://medicaldigest.org/scientific-contents/interview:intranasal-universal-influenza-vaccine-promising-data-blocking-virus-transmission

Hadley Wilson, ACC Immediate Past President shares his insights on the key announcements and findings at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:highlights-acc25

Benjamin H. Freed co-chaired an interesting session on Chronic Coronary Disease Management in 2025 at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:chronic-coronary-disease-management-2025-whats-new-guidelines

John K. Triedman shares his insights on the joint symposium of the Heart Rhythm Society and the American College of Cardiology, that will highlight recent guidelines and consensus documents in the arrhythmia field and updates since their publication. It's covering atrial fibrillation, conduction system pacing, management of arrhythmias in pregnancy, and management of athletes with arrhythmias....

Richard Kovacs shares his insights on key announcements and findings at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:chief-medical-officers-take-acc25

Martha Gulati shares her insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scientific Session. She discussed studies such as HORIZON and the ALPACA trial. Video: https://medicaldigest.org/scientific-contents/interview:why-lipoprotein-matters-clinical-decisions-and-patient-risk

Paul K. Whelton shares his insights on optimizing hypertension management at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:discussion-optimizing-hypertension-management-we-need-new-treatment-and-interventions

Christina Magnussen on individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:lifetime-benefit-control-modifiable-risk-factors

Tor Biering-Sørensen presented the analysis of the primary and secondary endpoint results of the DECODE-CKD at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:dapagliflozin-reduced-lvmi-patients-ckd-decode-ckd

Giulia Magnani explains a nurse-coordinated intensive intervention program emphasizing lifestyle and behavioral changes after ACS was associated with a 30% reduction in major adverse CV events for patients, primarily driven by a reduction in nonfatal MI, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-con...

Luke Laffin on the phase 2b Advance-HTN study of lorundrostat, whose results were reported in a late-breaking clinical trials presentation at the American College of Cardiology’s 2025 Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:lorundrostat-shows-continued-promise-against-uncontrolled-hypertension

Alan Brown shares his insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scientific Session. Why lipoprotein(a) matters for clinical decisions and patient risk? Video: https://medicaldigest.org/scientific-contents/interview:shifting-paradigm-lipoprotein-cardiovascular-disease

Raj Makkar explains data from 500 patients treated for aortic regurgitation with the Trilogy transcatheter aortic valve implantation system, point towards positive safety and efficacy outcomes with the device, alongside favourable valve performance at up to two years, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/...

Ankeet S. Bhatt shares his insights how real-world evidence and implementation science can improve ASCVD care at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:evidence-generation-implementation-tackling-unmet-need-ascvd

Heather L. Gornik shares her insights on future of care for patients with peripheral artery disease with the 2024 guidelines'. Video: https://medicaldigest.org/scientific-contents/interview:stepping-future-care-patients-peripheral-artery-disease-2024-guidelines-report-acc25 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery...

Stefan D. Anker explains among iron-deficient patients with heart failure with reduced ejection fraction, receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:intravenous-iron-offers-some-benefits...

Marc P. Bonaca explains semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:semagl...

Michael J. Reardon explains the new five-year data suggest transcatheter aortic valve replacement with a supra-annular, self-expanding valve is a safe and effective alternative to surgical aortic valve replacement when treating low-risk patients. In fact, hemodynamic data after five years consistently favors a transcatheter approach, according to a study presented at the American College of Cardio...

Darren K. McGuire explains people taking an oral formulation of semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke after an average follow-up of four years, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:oral-semaglut...

Joo-Yong Hahn shares his insights on the research presented at the American College of Cardiology's Annual Scientific Session. People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel rather than aspirin as their long-term antiplatelet therapy, according...

Isabelle Mahé shares her insights API-CAT trial were presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:low-dose-apixiban-comparable-full-dose-preventing-vte-recurrence-patients-cancer

Eileen M. Handberg, PhD, ARNP, FACC and C. Noel Bairey Merz, MD, FACC, FAHA shares their insights on the WARRIOR study, presented at the American College of Cardiology Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:warrior-study-intensive-medical-therapy-does-not-help-or-harm-women-chest-pain